EssilorLuxottica Société anonyme

OTC
ESLOY
Stock
Yield per half year: -1.8%
Dividend yield: 1.46%
Sector: Healthcare

EssilorLuxottica Société anonyme

160.00160.00150.00150.00140.00140.00130.00130.00120.00120.00110.00110.00100.00100.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
47.31 54.24 -12.77% 91.33 -48.19%
P/S 4.21 4.62 -8.88%
P/BV 2.62 4.2 -37.67%
P/FCF 27.81 16.2 71.66%
Ev/Ebitda 18.77 14.71 27.64%
Ev/S 4.64 4.05 14.52%
Ev/FCF 35.28 20.97 68.23%
E/P 0.0243 1.63 -98.51%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.71 25.2 -1.94% 24.59 +0.4882%
ROE 5.6 12.46 -55.09%
ROA 3.53 6.23 -43.41%
ROIC 0 15.34 -100%
ROS 8.9 12.71 -29.97%
ROCE 8.09 14.68 -44.9%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
6/10
2.1 6.22 -66.24% 2.05 +2.19%
Nеt Debt/Ebitda 1.74 -3.47 -150.12%
Debt/Ratio 0.2057 0.2246 -8.44%
Debt/Equity 0.5676 1 -43.32%
Debt/Net Income 5.83 18.36 -68.25%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.65/10
1.46 2.28 -36% 1.51 -3.31%
Number of years of dividend growth 3 1.59 88.5%
DSI 0.8571 0.7935 8.02%
Average dividend growth 10.09 -303.64 -103.32%
Average percentage for 5 years 1.51 2.59 -41.75%
Average percentage for payments 55.29 167.32 -66.96%
Difference from average difference in sector -0.8211

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
61.27 -98.5 -162.2%
Growth impulse Ebitda in 5 years 121.49 -98.62 -223.19%
Growth impulse Net Income in 5 years 2335.29 -98.32 -2475.19%
Growth impulse FCF in 5 years 32.87 -98.32 -133.43%
Growth impulse EPS in 5 years 16.2 -82.03 -119.75%
IP Score
5.58/10

Similar companies

Chugai Pharmaceutical Co., Ltd.

Astellas Pharma Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription